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Abstract
Mucositis is one of the most common side
effects of chemotherapy and radiotherapy. In
order to develop an evidence-based clinical
practice guideline for the management of tumor
therapy-induced-oral mucositis, it was neces-
sary to capture the patients’ perspective.
Therefore the aim of this critical literature
review was to explore the experience of patients
with therapy-induced-oral mucositis. Searches
were carried out using a systematic search
strategy in CINAHL and Medline. Qualitative
studies investigating the view of cancer
patients receiving chemotherapy and/or radio-
therapy and suffering from oral mucositis were
included. Study selection and quality assess-
ment were performed by two independent
reviewers. Only two qualitative studies (n=28
patients) met the inclusion criteria. Oral
mucositis caused by cancer therapy is associat-
ed with serious complications concerning pain,
eating, swallowing, speaking, sadness, lack of
energy, and distress. Mucositis was described
as the worst side effect of cancer therapy.
Providing patient-centered care requires under-
standing the experience and the needs of
patients and their families. Mucositis is associ-
ated with complex physical, psychological and
social consequences. Unfortunately, both stud-
ies were performed in different cultural back-
grounds and health care systems, so the results
cannot simply be transferred to German-speak-
ing countries. Further research is needed to
gain a deeper understanding of living with
mucositis.
Introduction
Chemotherapy and radiotherapy are associ-
ated with many side effects. Mucositis is
regarded as one of the most common side
effects of chemotherapy and radiotherapy.1
Mucosal lesions of various severity may cause
pain in mouth and throat area, induce problems
with food intake, limit patient’s quality of life
and have economic consequences. Cancer
patients with oral mucositis experience more
pain, often receive parenteral nutrition, require
more frequent consultations and higher emer-
gency costs and are hospitalized longer than
patients without mucositis.2,3 Furthermore,
mucositis may even become so intense that
tumor therapy has to be discontinued for a peri-
od of time.4,5 These problems present a major
challenge for tumor treatment. With symptoms
of mucositis and an increased risk of infection,
patients need more staff resources and cause
higher treatment costs. To meet these chal-
lenges, guidelines, studies and reports about
interventions for prevention or minimization of
mucositis are required.6 However, the meaning
of mucositis for cancer patients is rarely
addressed. 
In Switzerland there is no national strategy
at the federal level that prescribes the develop-
ment of guidelines in general. Ensuring the
supply mandate is largely the responsibility of
the 26 cantons in Switzerland (7 million
inhabitants). This results in 26 different
health care systems, which have only a few
interfaces. Therefore, it is it difficult to ensure
a common national policy strategy for health
care needs. The development of guidelines is
inconsistent and often does not correspond to
scientific standards. There is a lack of nation-
al evidence-based nursing guidelines which
could give recommendations for health care
facilities in Switzerland. To meet the needs for
evidence-based guidelines, the Oncology
Network Eastern Switzerland in collaboration
with the Swiss Centre for Evidence-Based
Nursing intends to develop guidelines for
oncology care on a consistent, high quality
level7 but with limited financial resources. The
methods are oriented on internationally estab-
lished rules for the development and adapting
of guidelines.8 Requirements are the identifi-
cation of patient-important outcomes and the
ranking of the relative importance of theses
outcomes. Therefore, the purpose of this study
was to examine patients’ experience with oral
mucositis. 
Methods of Research
A critical literature review was conducted
with the aim to provide an evidence-based sum-
mary of findings regarding patients’ experience
with oral mucositis. Searches were carried out
using a systematic search strategy in Medline
and CINAHL in January 2014. Qualitative stud-
ies with cancer patients receiving chemothera-
py and/or radiotherapy and suffering from oral
mucositis were included, independent of cancer
type and of the degree of mucositis. Only stud-
ies in German or English language were consid-
ered. Sensitive search strategies (Table 1) were
developed for each database using filters to
identify qualitative research.9,10 There were no
restrictions/ limits concerning age, date of study
or publication date. The reference lists of
included papers were checked for further stud-
ies. The literature search was performed by two
authors (DZ, EP). Titles and abstracts of all
studies identified were examined independent-
ly by two review authors (DZ, EP). If studies
appeared to meet the inclusion criteria or did
not allow a clear decision on the basis of title
and abstract, the full report was checked.
Disagreements were resolved by discussion. All
excluded studies were recorded, mentioning
specified reasons for exclusion.
Data extraction (research question, design,
sample, setting, data collection, results) and
assessment of the methodological quality were
carried out by two authors (DZ, EP) independ-
ently using the tool of Behrens and Langer.11
This tool addresses eleven specific domains,
namely research question, design, literature
search, selection of participants, description of
participants, description of the researcher, data
collection, data analysis, data saturation, pres-
entation of results, and validation of results.
Disagreements were resolved by discussion.
Each of the questions were answered with Yes,
No or Don’t know. In case of missing data, the
authors were contacted. The results of the
methodological quality assessment were pre-
sented graphically using Review Manager 5 of
the Cochrane Collaboration. The findings of the
studies were summarized without using a spe-
cial thematic synthesis12 due to the heterogene-
ity of the studies.
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Results
A total of 92 studies were identified (Figure
1). After reviewing titles and abstracts, 14 stud-
ies were identified as potentially relevant.13-26 
Reasons for exclusion (Table 2)13-26 were
quantitative study design and inadequate focus.
Finally two studies27,28 were included. The stud-
ies were conducted in Australia28 and Hong
Kong.27Quality assessment
Both authors were contacted to obtain miss-
ing information. 
Study quality of both studies was generally
good (Figure 2). The study of Borbasi et al.28
showed no insufficiency, whereas Cheng’s
study27 had minor deficiencies in study quality.
Only one item description of the researcher was
assessed with unclear, due to indistinct avail-
able data in the publication as well as insuffi-
cient information from the author.Description of studies
Cheng27 conducted semi-structured in-depth
interviews with 22 children (male=10, mean
age 12 years) who had developed oral mucositis
during chemotherapy and were treated at a can-
cer center in Hong Kong (Table 3). Further -
more, one parent of each family was also inter-
viewed about experience with oral mucositis
during chemotherapy (female=21, mean age 41
years). Using qualitative content analysis the
authors identified five categories: symptom
experience, negative emotional outcomes, the
dilemma of eating, challenges in oral care,
health care needs.
Children and their parents described oral
mucositis as the worst side effect of
chemotherapy, by far exceeding nausea and
vomiting. Symptom experience, especially
severe pain and swelling, can be called a con-
stant companion with serious complications
concerning eating, speaking, swallowing, and
pain. Children retired from social life because
of great pain and lack of energy/lethargy. The
correlation between symptoms and correspon-
ding reactions is caused by great distress of
children and parents. Children express stress-
ful experiences especially in forms of sadness,
anxiety and crying. 
Mucositis-associated eating and drinking
problems were a great challenge in the daily life
of children and their parents. Both experienced
the dilemma between hunger, pain, inability of
food intake and knowledge about the impor-
tance of nutrition for improving health status.
Parents reported great distress, having to force
their children to eat and drink. Parenteral nutri-
tion was not perceived as a positive solution.
Oral care caused the same problems and ten-
sions as food intake due to severe feelings of
pain. Unexpected and unprepared by profes-
sionals, children suffered from severe mucositis
(grade 3 and 4 according to WHO classifica-
tion). Therefore parents indicated the need for
more information about the disease process of
oral mucositis, risks, complications and food
selection. They also expressed their wish for
better mental preparation. Children needed
more emotional support from professionals dur-
ing oral mucositis. Moreover children and par-
ents have criticized the lack of pain manage-
ment. 
Borbasi et al.28 described similar issues in
their phenomenological study (Table 3). They
carried out in-depth interviews with six adult
patients (male=4, mean age 51.5 years) suffer-
ing from cytotoxic therapy in conjunction with
allogeneic hematopoietic stem cell transplanta-
tion. Study participants were recruited from a
special clinic for cancer patients in South
Australia. These patients experienced mucosi-
tis as a linear process consisting of three phas-
es: preparatory, peak and persisting phase. Five
categories were identified: presence of nurses,
therapeutic interventions, manifestation of
mucositis, distress with regard to eating and
the value of treatment No pain, no gain.
Important for participants was support of nurs-
ing staff during oral mucositis. Especially in
seemingly hopeless situations the nurses’ s
support and counseling was perceived as valu-
able and important. Study participants empha-
sized how important it was for them that nurs-
es respected their wishes and needs with regard
to treatment options. Therapeutic interventions
for oral care were followed strictly, if physically
possible. Participants reported manifestations
of mucositis in mouth, pharynx, esophagus and
stomach, which was leading to huge limitations
in food intake, requiring parenteral nutrition.
The experience of painful or impossible food
intake made aware the importance of food for
life. Mucositis was described as the worst side
effect of cancer therapy and was seen as a part
of cancer therapy which cannot be prevented to
become healthy again.
Discussion
The purpose of this review was to explore
patients’ experience of oral mucositis as a side
effect of chemo-/radiotherapy. There are a num-
ber of intervention trials and reviews about
mucositis, for example the use of amifostine for
the prevention and treatment of oral mucositis
in cancer patients.29 Even if it is known, that
mucositis is distressing, this study adds based
on a systematic review, that there is limited
Review
Figure 1. Flow chart of the selection process.
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research regarding patients’ experiences. Due
to the defined inclusion- and exclusion criteria,
a total of only two studies with 28 participants
could be included. The term qualitative and the
use of only two databases might have restricted
our search. We aimed to explore the meaning
that the patients hold about living with a
chemo-/radiotherapy caused mucositis. Mixed
and quantitative research designs were exclud-
ed because we were not interested in the extent
of burden. 
Both studies were of high methodological
quality. A synthesis of the findings was not per-
formed due to the limited number of studies,
different and small samples. Therefore, only an
approximate idea can be conveyed about the
meaning of mucositis for those affected by it. 
As results indicate, oral mucositis caused by
cancer therapy is associated with complex phys-
ical, psychological and social effects, and leads
to significant restrictions in daily life and well-
Review
Table 1. Search strategy.
Database and key words No. of results
CINAHL
S13 (S12) AND (S9) 67 
S12 (S10) AND (S11) 738 
S11 (S7) OR (S8) 194,195 
S10 (S5) OR (S6) 1223 
S9 (((S1) OR (S2)) OR (S3)) OR (S4) 396,269 
S8 neoplasm 41,817 
S7 cancer 175,075 
S6 mucositis 1223 
S5 oral mucositis 473 
S4 AB focus group* OR TI focus group* OR SU focus group* 26,701 
S3 AB interview* OR TI interview* OR SU interview* 169,830 
S2 SU questionnaire* or AB questionnaire* OR TI questionnaire* 250,097 
S1 Qualitative research OR AB qualitative OR TI Qualitative 48,167
MEDLINE
#9 "(((((neoplas*) AND cancer)) AND ((oral mucositis) AND mucositis))) AND (Search “interviews as topic”[Mesh:noexp] 20
OR “focus groups”[Mesh:noexp] OR narration[Mesh:noexp] OR qualitative research[Mesh:noexp] OR 
(((“semi-structured”[TIAB] OR semistructured[TIAB] OR unstructured[TIAB] OR structured[TIAB] OR informal[TIAB] 
OR “in-depth”[TIAB] OR indepth[TIAB] OR “face-to-face”[TIAB] OR guide[TIAB] OR guides[TIAB]) 
AND (interview*[TIAB] OR discussion*[TIAB] OR questionnaire*[TIAB])) OR (“focus group”[TIAB] OR “focus groups”
[TIAB] OR qualitative[TIAB] OR ethnograph*[TIAB] OR fieldwork[TIAB] OR “field work”[TIAB] OR “key informant”[TIAB]))
#8 "(((neoplas*) AND cancer)) AND ((oral mucositis) AND mucositis)" 1579
#7 "(neoplas*) AND cancer" 2,114,430
#6 "(oral mucositis) AND mucositis" 2934
#5 "mucositis" 6525
#4 "oral mucositis" 25,471
#3 "neoplas*" 2,156,107
#2 "cancer" 2,907,011
#1 “interviews as topic”[Mesh:noexp] OR “focus groups”[Mesh:noexp] OR narration[Mesh:noexp] OR qualitative research 211,080
[Mesh:noexp] OR (((“semi-structured”[TIAB] OR semistructured[TIAB] OR unstructured[TIAB] OR structured[TIAB] 
OR informal[TIAB] OR “in-depth”[TIAB] OR indepth[TIAB] OR “face-to-face”[TIAB] OR guide[TIAB] OR guides[TIAB]) 
AND (interview*[TIAB] OR discussion*[TIAB] OR questionnaire*[TIAB])) OR (“focus group”[TIAB] OR “focus groups”
[TIAB] OR qualitative[TIAB] OR ethnograph*[TIAB] OR fieldwork[TIAB] OR “field work”[TIAB] OR “key informant”[TIAB]))
Figure 2. Methodological quality summary.
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being of patients and their relatives. It causes
serious complications with regard to eating,
speaking, swallowing, pain, sadness, lack of
energy, and distress. Respondents described
mucositis as the worst side effect of cancer
therapy. 
In a widely cited study by Griffin et al.30 42%
of study participants receiving chemotherapy
showed signs of mucositis, which was assessed
as one of the most distressing effects of cancer
therapy, including hair loss, nausea and loss of
appetite. Griffin’s study was conducted already
in 1993. In the meantime, treatment opportuni-
ties concerning side effects like nausea or vom-
iting significantly improved. So mucositis cer-
tainly has another status today. 
None of the study participants expected the
severity of mucositis and such large restrictions
in daily life. This reflects a commonly observed
phenomenon in the care of patients with malig-
nant diseases. Immediately after the diagnosis
they receive a lot of information about the dis-
ease, its treatment and side effects. Shocked by
the diagnosis, they cannot integrate all given
information. So the scope of side effects will
become apparent only when patients begin to
suffer from them.
Due to pain and swelling, serious problems
with eating, drinking, talking and sleeping may
occur. The respondents reported high distress
related to eating and drinking which becomes
the major problem of their daily life.
Food rejection is alarming for relatives who
react with anxiety and put pressure on
patients.31 From the perspective of relatives,
encouragement for eating and drinking
expresses that they are worried about the
patient’s situation.32 
All study participants were aware how impor-
tant adequate oral care was to alleviate mucosi-
tis-associated pain. Nurses play a significant
role in assisting patients to tolerate their treat-
ment. Patients valued the range of individual
treatments and the nurses’ mental support.
Nevertheless, study participants expressed
their wishes for more emotional support of
healthcare professionals.
Surprisingly, we could not identify studies
which were conducted in our cultural back-
ground. So the findings were discussed with the
oncological nurses in the guideline develop-
ment group regarding transferability. The nurs-
es confirmed the categories identified by the
authors of the two studies. Six patient-relevant
outcome measures were determined based on
this literature review and the experience of the
nurses. Patient-relevant outcomes address:
pain, prevention of infectious diseases, eating
and drinking, xerostomia, sleep disorders, and
impaired sense of taste. According to the
patient-relevant outcomes 29 clinical questions
were formulated, which should be answered by
means of the guideline. 
Review
Table 3. Summary of included studies.
Borbasi et al., 200228
Research question/aim What are the experiences with mucositis in patients who are receiving intensive cytotoxic treatment associated 
with autologous haematopoietic stem cell transplantation?
Design Interpretive phenomenological study
Sample, setting Six patients: 4 women, 2 men, age range 38-63 years; metropolitan teaching hospital in South Australia
Data collection Weekly indepth interviews for 4 weeks and at week 8,  week 12 or until the symptoms of oral mucositis had resolved; 
interviews: 45 min to 1 h; total of 19 interviews
Cheng, 200927
Research question/aim Description of children’s and their parents’ lived experiences of oral mucositis and to explore their needs 
in relation to oral mucositis
Design Descriptive phenomenological study
Sample, setting 22 pediatric cancer patients and their parents; children: mean age 12.1 years (SD 3.4), 12 males; ALL (n=9), osteosarcoma
(n=7); parents: mean age 41.1 years (SD 8.3), 21 (95%) females; children’s cancer center of a regional university 
hospital in Hong Kong
Data collection Semi-structured interviews; children’s interviews 20 to 30 min, interviews with parents 30 to 40 min
SD, standard deviation; ALL, acute lymphoblastic leukemia.
Table 2. Reasons of excluded studies.
Reference Reason of exclusion
Armstrong and McCaffrey, 200613 Inadequate focus: quality of life
Goldberg et al., 200414 Study design does not fit: quantitative research design
Cheng, 200715 Study design does not fit: quantitative research design
Chen, 200816 Study design does not fit: quantitative research design
Dodd et al., 200117 Study design does not fit: quantitative research design
Ethier et al., 201218 Study design does not fit: quantitative research design
Green et al., 201019 Inadequate focus: eating problems due to nausea and mucositis
Miller et al., 200720 Inadequate focus: feasibility and acceptability of an oral care diary
Riordain et al., 201121 Study design does not fit: quantitative research design 
Riordain et al., 201122 Inadequate sample: patients with chronic mucositis independent of cause
Rose-Ped et al., 200223 Study design does not fit: quantitative research design
Larsson et al., 200324 Inadequate focus: eating problems
Syrjala et al., 200425 Study design does not fit: quantitative research design
Wong et al., 200626 Study design does not fit: quantitative research design
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Study limitations
The review has some limitations. Due to lim-
itations of financial resources we could not
carry out hand-searching, involve an informa-
tion scientist and use more databases. We tried
to find the existing literature using a broad
search strategy and checking the reference
lists. Therefore existing studies may have
almost completely detected. Although few stud-
ies have been found, this review can be a basis
for further research.
Conclusions
In order to develop an evidence-based clinical
practice guideline for management of tumor
therapy-induced oral mucositis, it was neces-
sary to capture the patient’s perspective. Oral
mucositis caused by cancer therapy is associat-
ed with serious complications concerning pain,
eating, swallowing, speaking, sadness, lack of
energy, and distress. Mucositis was described
as the worst side effect of cancer therapy.
Patient-relevant outcomes address pain, pre-
vention of infectious diseases, eating and drink-
ing, xerostomia, sleep disorders, and impaired
sense of taste. Even if nurses in the guideline
development group largely confirmed the
results, it is necessary to examine the experi-
ence of mucositis in German speaking coun-
tries in order to derive meaningful recommen-
dations for health care professionals. It is very
resource-consuming to develop guidelines for
individual cantons. Therefore a national strate-
gy would be helpful.
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